Comparison between Brainbees Solutions IPO and Emcure Pharmaceuticals IPO.
Brainbees Solutions IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Emcure Pharmaceuticals IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Brainbees Solutions IPO is up to ₹4,193.73 Cr whereas the issue size of the Emcure Pharmaceuticals IPO is up to ₹1,952.03 Cr. The final issue price of Brainbees Solutions IPO is ₹465.00 per share and of Emcure Pharmaceuticals IPO is ₹1,008.00 per share.
| Brainbees Solutions IPO | Emcure Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹10 per share |
| Issue Price (Lower) | ₹440.00 per share | ₹960.00 per share |
| Issue Price (Upper) | ₹465.00 per share | ₹1,008.00 per share |
| Issue Price (Final) | ₹465.00 per share | ₹1,008.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹44.00 per share | ₹90.00 per share |
| Market Lot Size | 32 shares | 14 shares |
| Fresh Issue Size | 3,58,34,699 shares | 79,46,231 shares |
| Fresh Issue Size (Amount) | up to ₹1,666.19 Cr | up to ₹800.58 Cr |
| OFS Issue Size | 5,43,59,733 shares | 1,14,28,839 shares |
| OFS Issue Size (Amount) | up to ₹2,527.54 Cr | up to ₹1,151.45 Cr |
| Issue Size Total | 9,01,94,432 shares | 1,93,75,070 shares |
| Issue Size Total (Amount) | up to ₹4,193.73 Cr | up to ₹1,952.03 Cr |
Brainbees Solutions IPO opens on Aug 06, 2024, while Emcure Pharmaceuticals IPO opens on Jul 03, 2024. The closing date of Brainbees Solutions IPO and Emcure Pharmaceuticals IPO is Aug 08, 2024, and Jul 05, 2024, respectively.
| Brainbees Solutions IPO | Emcure Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | Aug 05, 2024 | Jul 02, 2024 |
| Issue Open | Aug 06, 2024 | Jul 03, 2024 |
| Issue Close | Aug 08, 2024 | Jul 05, 2024 |
| Basis Of Allotment (Tentative) | Aug 09, 2024 | Jul 08, 2024 |
| Initiation of Refunds (Tentative) | Aug 12, 2024 | Jul 09, 2024 |
| Credit of Share (Tentative) | Aug 12, 2024 | Jul 09, 2024 |
| Listing date (Tentative) | Aug 13, 2024 | Jul 10, 2024 |
| Anchor Lockin End date 1 | Sep 08, 2024 | Aug 07, 2024 |
| Anchor Lockin End date 2 | Nov 07, 2024 | Oct 06, 2024 |
Brainbees Solutions IPO P/E ratio is -69.91, as compared to Emcure Pharmaceuticals IPO P/E ratio of 34.55.
| Brainbees Solutions IPO | Emcure Pharmaceuticals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 83.21 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 78.08 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | -69.91 | 34.55 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹24141.75 Cr. | ₹19029.89 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 16.90% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 19.37% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.67 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹-6.65 | ₹29.17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | -8.65% | 16.87% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Brainbees Solutions IPO Retail Individual Investors (RII) are offered 90,12,317 shares while in Emcure Pharmaceuticals IPO retail investors are offered 90,12,317 shares. Qualified Institutional Buyers (QIB) are offered 2,70,36,953 shares in Brainbees Solutions IPO and 38,53,234 shares in Emcure Pharmaceuticals IPO.
| Brainbees Solutions IPO | Emcure Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | 4,05,55,428 shares | 57,79,850 shares |
| Market Maker Reservation | ||
| QIB | 2,70,36,953 shares | 38,53,234 shares |
| NII | 1,35,18,476 shares | 28,89,926 shares |
| RII | 90,12,317 shares | 67,43,160 shares |
| Employee | 71,258 shares | 1,08,900 shares |
| Others | ||
| Total | 9,01,94,432 shares | 1,93,75,070 shares |
Brainbees Solutions IPO subscribed 12.22x in total, whereas Emcure Pharmaceuticals IPO subscribed 67.87x.
| Brainbees Solutions IPO | Emcure Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 19.30x | 191.24x |
| NII (times) | 4.68x | 49.32x |
| Big NII (times) | 5.32x | 54.90x |
| Small NII (times) | 3.39x | 38.16x |
| RII (times) | 2.31x | 7.36x |
| Employee (times) | 6.57x | 8.81x |
| Other (times) | ||
| Total (times) | 12.22x | 67.87x |
